改良恶性风险指数联合哥本哈根指数鉴别诊断卵巢肿瘤良恶性的价值  

Value of modified malignancy risk index combined with Copenhagen index in the differential diagnosis of benign and malignant ovarian tumors

作　　者：李小利 潘志 刘传金 徐博雁 LI Xiaoli;PAN Zhi;LIU Chuanjin;XU Boyan(Department of Ultrasound,Taizhou Woman and Children’s Hospital,Zhejiang 318001,China)

机构地区：[1]浙江省台州市妇女儿童医院超声科,318001 [2]浙江省台州市仙居县人民医院超声科 [3]浙江省温岭市第四人民医院超声科

出　　处：《临床超声医学杂志》2022年第6期469-472,共4页Journal of Clinical Ultrasound in Medicine

摘　　要：目的探讨改良恶性风险指数(RMI)联合哥本哈根指数(CPH-I)在卵巢肿瘤良恶性鉴别诊断中的价值。方法回顾性分析经我院手术病理证实的206例卵巢肿瘤患者的临床资料,根据病理结果分为良性组152例和恶性组54例。分析RMI1、RMI2、RMI3、RMI4鉴别诊断卵巢肿瘤良恶性的价值,采用Kappa检验分析其与病理结果的一致性。对鉴别诊断价值最高的RMI进行改良,获得改良RMI,进一分析改良RMI、CPH-I及其联合对卵巢肿瘤良恶性的鉴别诊断价值,采用Kappa检验分析其与病理结果的一致性。结果RMI1、RMI2、RMI3、RMI4鉴别诊断卵巢肿瘤良恶性的敏感性分别为77.78%、79.63%、77.78%、81.48%,特异性分别为70.39%、71.71%、71.71%、73.02%,与病理结果的一致性均一般(Kappa=0.402、0.431、0.418、0.460,均P<0.05)。对诊断效能最高的RMI4进行改良,改良RMI、CPH-I及其联合与病理结果的一致性均较好(Kappa=0.739、0.713、0.798,均P<0.05)。改良RMI联合CPH-I鉴别诊断卵巢肿瘤良恶性的敏感性、特异性、阳性预测值、阴性预测值及准确率均最高(92.59%、91.44%、79.37%、97.20%、91.75%),与其单独应用比较差异均有统计学意义(均P<0.05)。结论改良RMI联合CPH-I对卵巢肿瘤良恶性有较好的鉴别诊断价值。ObjectiveTo investigate the value of the modified malignancy risk index(RMI)combined with Copenhagen index(CPH-I)in the differential diagnosis of benign and malignant ovarian tumors.MethodsThe clinical data of206 patients with ovarian tumors confirmed by surgery and pathology in our hospital were retrospectively analyzed.According to the pathological results,they were divided into a benign group of 152 cases and a malignant group of 54 cases.The value of RMI1,RMI2,RMI3 and RMI4 in the differential diagnosis of benign and malignant ovarian tumors were analyzed,and Kappa test was used to analyze their consistency with pathology.The RMI with the highest differential diagnostic value was modified,mRMI was obtained,and the differential diagnostic value of mRMI,CPH-I and their combination for benign and malignant ovarian tumors was further explored,Kappa test was used to analyze their consistency with pathology.ResultsThe sensitivity of RMI1,RMI2,RMI3,and RMI4 in the differential diagnosis of benign and malignant ovarian tumors were 77.78%,79.63%,77.78%and 81.48%,respectively,and the specificity were 70.39%,71.71%,71.71%and 73.02%,respectively.The consistency with pathology was general(Kappa=0.402,0.431,0.418,0.460,all P<0.05).mRMI,CPH-I and their combination were in good consistency with pathology(Kappa=0.739,0.713,0.798,all P<0.05).The sensitivity,specificity,positive predictive value,negative predictive value and accuracy of mRMI combined with CPH-I in the differential diagnosis of benign and malignant ovarian tumors were the highest(92.59%,91.44%,79.37%,97.20%,91.75%),and the differences were statistically significant compared with mRMI and CPH-I alone(all P<0.05).Conclusion differential diagnosis of benign and malignant ovarian tumors.

关 键 词：超声检查 恶性风险指数 哥本哈根指数 卵巢肿瘤 良恶性 

分 类 号：R445.1[医药卫生—影像医学与核医学] R737.31[医药卫生—诊断学]